Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coagulation01:09

Coagulation

8.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.7K
Coagulation01:06

Coagulation

563
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
563
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.5K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.5K
Introduction to Hemostasis01:05

Introduction to Hemostasis

11.3K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
11.3K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.5K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The need for dried plasma-Still a national issue: Where are we and recommendations.

Transfusion·2026
Same author

Methodological Considerations Regarding Platelet Inhibition in Functional Fibrinogen Assessment.

Anesthesia and analgesia·2026
Same author

Traumatic hemothorax activates complement, stimulates proinflammatory cytokine release, and primes neutrophils for local inflammatory reactive oxygen species production.

The journal of trauma and acute care surgery·2026
Same author

Is "Physiological Lysis" in Viscoelastometry a Plasmin-Mediated Process?

Diagnostics (Basel, Switzerland)·2026
Same author

The ethics of blood stewardship and quantitative futility assessments to predict certain death in neurotrauma patients.

Frontiers in medicine·2026
Same author

Comparison between the automated TEG®6s and viscoelastic analyzer Haema T4.

Korean journal of anesthesiology·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026
Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026
Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026
See all related articles

Related Experiment Video

Updated: Nov 7, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

959

Trauma-induced coagulopathy.

Ernest E Moore1,2, Hunter B Moore3, Lucy Z Kornblith4

  • 1Ernest E Moore Shock Trauma Center at Denver Health, Denver, CO, USA. Ernest.Moore@dhha.org.

Nature Reviews. Disease Primers
|April 30, 2021
PubMed
Summary
This summary is machine-generated.

Trauma-induced coagulopathy (TIC) involves early bleeding and later clotting risks. Effective management requires controlling hemorrhage and shock to improve patient outcomes and reduce long-term morbidity.

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.2K
Pseudofracture: An Acute Peripheral Tissue Trauma Model
10:08

Pseudofracture: An Acute Peripheral Tissue Trauma Model

Published on: April 18, 2011

15.0K

Related Experiment Videos

Last Updated: Nov 7, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

959
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.2K
Pseudofracture: An Acute Peripheral Tissue Trauma Model
10:08

Pseudofracture: An Acute Peripheral Tissue Trauma Model

Published on: April 18, 2011

15.0K

Area of Science:

  • Trauma and Emergency Medicine
  • Hematology
  • Pathophysiology

Background:

  • Uncontrolled hemorrhage is a leading preventable cause of death in trauma patients.
  • Trauma-induced coagulopathy (TIC) is a complex condition with early hypocoagulability and later hypercoagulability.
  • The 'lethal triad' (coagulopathy, hypothermia, acidosis) exacerbates TIC development.

Purpose of the Study:

  • To review the pathophysiology, diagnosis, and management of trauma-induced coagulopathy.
  • To highlight the distinct role of traumatic brain injury in TIC.
  • To discuss current treatment strategies and their limitations.

Main Methods:

  • Review of pathophysiological mechanisms of TIC.
  • Analysis of laboratory diagnostic methods for coagulopathy.
  • Examination of current management priorities and therapeutic interventions.

Main Results:

  • TIC involves fibrinogen depletion, impaired thrombin generation, platelet dysfunction, and dysregulated fibrinolysis.
  • Laboratory diagnoses may not always correlate with clinical presentation.
  • Optimal blood product composition for resuscitation remains internationally debated.

Conclusions:

  • Prompt control of hemorrhage and shock is crucial for managing TIC.
  • Tranexamic acid use varies globally in pre-hospital settings.
  • TIC survivors face significant short- and long-term morbidity, impacting quality of life.